The chick separation stress paradigm: A validation study

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 2, 2004, Pages 221-226

  Feltenstein, Matt W ^a   Warnick, Jason E ^a   Guth, Amanda N ^a   Sufka, Kenneth J ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Anxiety; Anxiolytic screen; Domestic fowl; Separation stress; Validation

Indexed keywords

AMPHETAMINE; ANXIOLYTIC AGENT; BUSPIRONE; CAFFEINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLONIDINE; HALOPERIDOL; IMIPRAMINE; MEPROBAMATE; PENTOBARBITAL; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CHICKEN; CONTROLLED STUDY; DISTRESS SYNDROME; DOSE RESPONSE; DRUG EFFECT; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; SEDATION; SEPARATION ANXIETY; SLEEP; STEREOTYPY; STRESS; VOCALIZATION;

GALLIFORMES;

EID: 1642575211     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.10.019     Document Type: Article

References (46)

1. Baldwin H.A., Johnston A.L., File S.E. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur. J. Pharmacol. 159:1989;211-215.
2. Berger F.M. The pharmacological properties of 2-methyl-2-n-propyl-1,3 propanediol dicarbamate (Miltown), a new interneuronal blocking agent. J. Pharmacol. Exp. Ther. 112:1954;413-423.
3. Bhattacharya S.K., Satyan K.S., Chakrabarti A. Anxiogenic action of caffeine: an experimental study in rats. J. Psychopharmacol. 11:1997;219-224.
4. Borsini F., Podhorna J., Marazziti D. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl.). 163:2002;121-141.
5. Broekkamp C.L., Rijk H.W., Joly-Gelouin D., Lloyd K.L. Major tranquilizers can be distinguished from minor tranquilizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur. J. Pharmacol. 126:1986;223-229.
6. Cavero I., Roach A.G. The effects of prazosin on the clonidine induced hypotension and bradycardia in rats and sedation in chicks. [proceedings] Br. J. Pharmacol. 62:1978;468P-469P.
7. Crawley J.N. Neuropharmacologic specificity of a simple animal model for the behavioral actions using benzodiazepines. Pharmacol. Biochem. Behav. 15:1981;695-699.
8. Delong R.E., Phillis J.W., Barraco R.A. A possible role of endogenous adenosine in the sedative action of meprobamate. Eur. J. Pharmacol. 118:1985;359-362.
9. De Vry J., Benz U., Schreiber R., Traber J. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur. J. Pharmacol. 249:1993;331-339.
10. Feltenstein M.W., Ford N.G., Freeman K.B., Sufka K.J. Dissociation of stress behaviors in the chick social-separation-stress procedure. Physiol. Behav. 75:2002;675-679.
11. Feltenstein M.W., Lambdin L.C., Ganzera M., Dharmaratne H.R.W., Nanayakkara N.P.D., Khan I.A.et al. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure. Phytother. Res. 17:2003;210-216.
12. Feltenstein M.W., Lambdin L.C., Webb H.E., Warnick J.E., Khan S.I., Khan I.A.et al. Corticosterone response in the chick separation-stress paradigm. Physiol. Behav. 78:2003;489-493.
13. Geller I., Seifter J. The effects of meprobamate, barbiturates, D-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia. 1:1960;482-492.
14. Graeff F.G., Netto C.F., Zangrossi H. Jr. The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 23:1998;237-246.
15. Green S., Hodges H. Animal models of anxiety. Willner P. Behavioural models in psychopharmacology: theoretical, industrial and clinical perspectives. 1991;21-49 Cambridge Univ. Press, Cambridge (MA).
16. Harvey S.C. Hypnotics and sedatives. Gilman A.G., Goodman L.S., Gilman A. The pharmacological basis of therapeutics. 6th ed. 1980;339-375 Macmillan, New York.
17. Hascoet M., Bourin M. A new approach to the light/dark test procedure in mice. Pharmacol. Biochem. Behav. 60:1998;645-653.
18. Hjorth S., Auerbach S.B. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav. Brain. Res. 73:1996;281-283.
19. Howard J.L., Rohrbach K.W., Pollard G.T. Cumulative dose-effect curves in a conflict test with incremental shock. Psychopharmacology (Berl.). 78:1982;195-196.
20. King J.A., Messenger T., Ferris C.F. Seed finding in golden hamsters: a potential animal model for screening anxiolytic drugs. Neuropsychobiology. 45:2002;150-155.
21. Lambdin L.C., Guth A.N., Feltenstein M.W., Sufka K.J. Validation of the chick social-separation stress procedure as a screen for anxiolytic compounds. Soc. Neurosci. Abstr. 2002;571.20.
22. Lecci A., Borsini F., Volterra G., Meli A. Pharmacological validation of a novel animal model of anticipatory anxiety in mice. Psychopharmacology (Berl.). 101:1990;255-261.
23. McCloskey T.C., Paul B.K., Commissaris R.L. Buspirone effects in an animal conflict procedure: comparison with diazepam and Phenobarbital. Pharmacol. Biochem. Behav. 27:1987;171-175.
24. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70:2003;83-244.
25. Molewijk H.E., van der Poel A.M., Mos J., van der Heyden J.A., Olivier B. Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology (Berl.). 117:1995;32-40.
26. Olsen C.K., Hogg S., Lapiz M.D. Tonic immobility in guinea pigs: a behavioural response for detecting an anxiolytic-like effect? Behav. Pharmacol. 13:2002;261-269.
27. Panksepp J., Meeker R., Bean N.J. The neurochemical control of crying. Pharmacol. Biochem. Behav, 12:1980;437-443.
28. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
29. Rodina V.I., Krupina N.A., Kryzhanovskii G.N. A new natural model of elevated anxiety in rats. Biull. Eksp. Biol. Med. 116:1993;127-130.
30. Rowan M.J., Cullen W.K., Moulton B. Buspirone impairment of performance of passive avoidance and spatial learning tasks in the rat. Psychopharmacology (Berl.). 100:1990;393-398.
31. Russell K.H., Hagenmeyer-Houser S.H., Sanberg P.R. Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome. Psychopharmacology (Berl.). 91:1987;45-49.
32. Salt J.S., Taberner P.V. Differential effects of benzodiazepines and amphetamine on exploratory behaviour in weanling rats: an animal model for anxiolytic activity. Prog. Neuropsychopharmacol. 8:1984;163-169.
33. Sanchez C. Stress-induced vocalization in adult animals. A valid model of anxiety? Eur. J. Pharmacol. 463:2003;133-143.
34. Shimada T., Matsumoto K., Osanai M., Matsuda H., Terasawa K., Watanabe H. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenics drugs. Gen. Pharmacol. 26:1995;205-210.
35. Smith K.K., Dharmaratne H.R.W., Feltenstein M.W., Broom S.L., Roach J.T., Nanayakkara N.P.D.et al. Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. Psychopharmacology (Berl.). 155:2001;86-90.
36. Smythe J.W., Murphy D., Bhatnagar S., Timothy C., Costall B. Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacol. Biochem. Behav. 54:1996;57-63.
37. Stephens D.N., Andrews J.S. Screening for anxiolytic drugs. Willner P. Behavioural models in psychopharmacology: theoretical, industrial and clinical perspectives. 1991;50-75 Cambridge Univ. Press, Cambridge (MA).
38. Sufka K.J., Weed N.C. Construct validation of behavioral indices of isolation stress and inflammatory nociception in young domestic fowl. Physiol. Behav. 55:1994;741-746.
39. Sufka K.J., Hughes R.A., McCormick T.M., Borland J.L. Opiate effects on isolation stress in domestic fowl. Pharmacol. Biochem. Behav. 49:1994;1011-1015.
40. Sufka K.J., Roach J.T., Chambliss W.J. Jr., Broom S.L., Feltenstein M.W., Wyandt C.M.et al. Anxiolytic properties of botanical extracts in the chick social separation-stress procedure. Psychopharmacology (Berl.). 153:2001;219-224.
41. Teixeira R.C., Zangrossi H., Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol. Biochem. Behav. 65:2000;571-576.
42. Vogel J.R., Beer B., Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. 21:1971;1-7.
43. Watson G.S., Sufka K.J. Chlordiazepoxide reverses social-separation- induced distress vocalizations and analgesia in young domestic fowl. Exp. Clin. Psychopharmacol. 4:1996;347-353.
44. Watson G.S., Roach J.T., Sufka K.J. Benzodiazepine receptor function in the chick social separation-stress procedure. Exp. Clin. Psychopharmacol. 7:1999;83-89.
45. Willner P. Behavioural models in psychopharmacology. Willner P. Behavioural models in psychopharmacology. Theoretical, industrial, and clinical perspectives. 1991;3-18 Cambridge Univ. Press, Cambridge (MA).
46. Wolgin D.L. Development and reversal of sensitization to amphetamine-induced hypophagia: role of temporal, pharmacological, and behavioral variables. Psychopharmacology. 117:1995;49-54.